PharmaLogic Holdings Corp. (“PharmaLogic” or “the Company”), a leading contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, announces that it will acquire a majority stake in Agilera Pharma AS (“Agilera”) from the Institute for Energy Technology (IFE) in Norway, marking a significant step forward in the company’s strategy to create the first fully-integrated, global CDMO specializing in radiopharmaceutical therapies. Agilera has been a trusted partner for major pharmaceutical companies for more than a decade, manufacturing commercial radiopharmaceutical therapies across the United States, Europe, and Asia.
Read the full article: PharmaLogic to Acquire Majority Stake in Agilera, Strengthening Global Expertise in Radiopharmaceutical Therapeutics //
Source: https://www.prnewswire.com/news-releases/pharmalogic-to-acquire-majority-stake-in-agilera-strengthening-global-expertise-in-radiopharmaceutical-therapeutics-302424316.html